Cannell & Spears’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.87M | Sell |
9,071
-1
| -0% | -$536 | 0.1% | 140 |
|
|
2025
Q1 | $3.81M | Buy |
9,072
+7,901
| +675% | +$3.32M | 0.08% | 154 |
|
|
2024
Q4 | $484K | Sell |
1,171
-399
| -25% | -$165K | 0.01% | 288 |
|
|
2024
Q3 | $793K | Buy |
1,570
+400
| +34% | +$202K | 0.02% | 258 |
|
|
2024
Q2 | $570K | Sell |
1,170
-400
| -25% | -$195K | 0.01% | 260 |
|
|
2024
Q1 | $848K | Buy |
1,570
+400
| +34% | +$216K | 0.02% | 238 |
|
|
2023
Q4 | $649K | Hold |
1,170
| – | – | 0.05% | 122 |
|
|
2023
Q3 | $512K | Hold |
1,170
| – | – | 0.04% | 131 |
|
|
2023
Q2 | $588K | Buy |
1,170
+400
| +52% | +$201K | 0.05% | 126 |
|
|
2023
Q1 | $385K | Hold |
770
| – | – | 0.03% | 159 |
|
|
2022
Q4 | $314K | Buy |
+770
| New | +$314K | 0.03% | 175 |
|